Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Systematic meta-analysis and replication of genome-wide expression studies identifies molecular pathways of Parkinson’s disease

ABSTRACT: Analysis of human dopamine (DA) from postmortem brains of 8 patients with Parkinson’s disease (PD). Results provide insight into the molecular processes perturbed in the PD substantia nigra. Human dopamine (DA) neurons from 8 PD and 9 control subjects were obtained. Double-stranded complementary DNA was made with a biotinylated T7(dT)-24 primer. Biotinylated complementary RNA was fragmented and hybridized to Affymetrix human genome U133_X3P microarrays. The Affymetrix .CEL files were normalized to “all probe sets” in a standardized matter, and scaled to 100 by the MAS5 algorithm implemented in the Bioconductor package.

ORGANISM(S): Homo sapiens

SUBMITTER: Bin Zheng 

PROVIDER: E-GEOD-24378 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Zheng Bin B   Liao Zhixiang Z   Locascio Joseph J JJ   Lesniak Kristen A KA   Roderick Sarah S SS   Watt Marla L ML   Eklund Aron C AC   Zhang-James Yanli Y   Kim Peter D PD   Hauser Michael A MA   Grünblatt Edna E   Moran Linda B LB   Mandel Silvia A SA   Riederer Peter P   Miller Renee M RM   Federoff Howard J HJ   Wüllner Ullrich U   Papapetropoulos Spyridon S   Youdim Moussa B MB   Cantuti-Castelvetri Ippolita I   Young Anne B AB   Vance Jeffery M JM   Davis Richard L RL   Hedreen John C JC   Adler Charles H CH   Beach Thomas G TG   Graeber Manuel B MB   Middleton Frank A FA   Rochet Jean-Christophe JC   Scherzer Clemens R CR  

Science translational medicine 20101001 52

Parkinson's disease affects 5 million people worldwide, but the molecular mechanisms underlying its pathogenesis are still unclear. Here, we report a genome-wide meta-analysis of gene sets (groups of genes that encode the same biological pathway or process) in 410 samples from patients with symptomatic Parkinson's and subclinical disease and healthy controls. We analyzed 6.8 million raw data points from nine genome-wide expression studies, and 185 laser-captured human dopaminergic neuron and sub  ...[more]

Similar Datasets

Transcriptomics Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 3
2011-01-20 | E-GEOD-20164 | biostudies-arrayexpress
Unknown Systematic meta-analysis and replication of genome-wide expression studies identifies molecular pathways of Parkinson’s disease
2011-01-20 | GSE24378 | GEO
Transcriptomics Systematic meta-analysis and replication of genome-wide expression studies of Parkinson’s disease: 4
2011-01-20 | E-GEOD-20314 | biostudies-arrayexpress
Transcriptomics Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 2
2011-01-20 | E-GEOD-20163 | biostudies-arrayexpress
Unknown Systematic meta-analysis and replication of genome-wide expression studies of Parkinson’s disease: 4
2011-01-20 | GSE20314 | GEO
Transcriptomics aCGH study of iPS cells from two normal subjects and two Parkinson's disease patients with parkin mutations
2012-01-21 | E-GEOD-35190 | biostudies-arrayexpress
Unknown aCGH study of iPS cells from two normal subjects and two Parkinson's disease patients with parkin mutations
2012-01-21 | GSE35190 | GEO
Unknown Systematic meta-analysis and replication of genome-wide expression studies of Parkinson's disease: 3
2011-01-20 | GSE20164 | GEO
Transcriptomics The transcriptional modulator H2AFY marks Huntington's disease activity in men and mice
2011-09-01 | E-GEOD-24250 | biostudies-arrayexpress
Unknown Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
2022-03-23 | GSE196441 | GEO